Skip to main content

Table 1 Indicators of the immune status in patients with chronic respiratory diseases, mean ± SE

From: Modification of the fatty acid composition of the erythrocyte membrane in patients with chronic respiratory diseases

Indicators

Healthy subjects n = 10

Patient with chronic bronchitis, n = 15

Patients with chronic obstructive pulmonary disease n = 15

PAN, %

64.52 ± 0.68

59.90 ± 0.88*

57.52 ± 1.96*

TNFα, pg/ml

2.60 ± 0.03

7.89 ± 1.47***

×4.3 ± 0.3***

sTNF-RI, pg/ml

789.1 ± 7.10

1595.58 ± 141.53***

1523.4 ± 11.0***

bFGF, pg/ml

38.3 ± 0.8

38.93 ± 1.54

×53.9 ± 0.3***

TGF-β, pg/ml

1865.4 ± 11.3

1479.17 ± 19.60**

×48145.0 ± 20.6***

IL-8, pg/ml

11.5 ± 1.9

17.40 ± 1.20***

×13.4 ± 1.6

  1. PAN – phagocytic activity of the neutrophils. Asteriks indicate significant differences of indicators between patients with respiratory diseases and healthy subjects: * for р < 0.05; ** for р < 0.01; *** for р < 0.001. Asteriks indicate significant differences of fatty acid contents between patients with chronic bronchitis and with chronic obstructive pulmonary disease: × for р < 0.001.
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X